Clinical trial
Bio-behavioral Lung Cancer Prevention Program
NCT00322205 · National Institutes of Health (NIH), NIH · Completed
Key facts
| NCT number | NCT00322205 |
|---|---|
| Title | Bio-behavioral Lung Cancer Prevention Program |
| Official title | Bio-behavioral Lung Cancer Prevention Program |
| Lead sponsor | National Institutes of Health (NIH), NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Smoking Cessation |
| Intervention type | Drug |
| Interventions | zyban |
| Enrollment | 555 |
| Start date | Jun 1, 1999 |
| Completion | Mar 1, 2002 |
| First posted | May 5, 2006 |
| Last update posted | Jan 11, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: